Astrocytomas are associated with all of the following syndromes, except
neurofibromatosis type 2
The exception is neurofibromatosis type 2 (NF2). NF2 results from mutation of the NF2 (merlin/schwannomin) gene on chromosome 22q12 and is characterised by bilateral vestibular schwannomas, along with meningiomas, other cranial and spinal schwannomas, ependymomas and juvenile posterior subcapsular cataract. Astrocytic tumours are not part of its classical spectrum.
The other three are genuinely astrocytoma-associated. Neurofibromatosis type 1 (neurofibromin, chromosome 17q11) classically causes optic pathway gliomas and brainstem pilocytic astrocytomas, with cafe-au-lait macules, Lisch nodules, axillary freckling and neurofibromas. Li-Fraumeni syndrome (germline TP53) predisposes to astrocytoma and glioblastoma besides sarcoma, breast and adrenocortical carcinoma. Cowden disease (germline PTEN) features the cerebellar dysplastic gangliocytoma of Lhermitte-Duclos disease with trichilemmomas and thyroid and breast tumours.
Key point: NF1 gives optic nerve gliomas; NF2 gives bilateral vestibular schwannomas and meningiomas - a favourite one-line discriminator.
The principle of adaptation shown in the following diagram (depicting the skull containing venous blood, arterial blood, brain, mass, and CSF within a fixed volume) is explained by
